Cystic Fibrosis Therapeutics Market Size, Share & Growth Report 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Cystic Fibrosis Therapeutics Market, 2024–2032 (USD Billion)
  • 2.2. Cystic Fibrosis Therapeutics Market: Snapshot
• Chapter 3. Global Cystic Fibrosis Therapeutics Market– Industry Analysis
  • 3.1. Cystic Fibrosis Therapeutics Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Introduction of anti-inflammatory therapy and mucus-alteration & airway surface liquid modulation therapy are anticipated to propel the market growth over 2024-2032.
    • 3.2.2. The new kind of medical treatments termed as cystic fibrosis transmembrane conductance regulator (CFTR) modulators are effectively targeting myriad kinds of mutations occurring in cystic fibrosis transmembrane conductance regulator gene that is responsible for causing cystic fibrosis. This, in turn, will further drive the market growth.
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Route of Administration
    • 3.4.2. Market attractiveness analysis By Drug Class
• Chapter 4. Global Cystic Fibrosis Therapeutics Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Cystic Fibrosis Therapeutics Market: company market share, 2024
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Vehicle launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Cystic Fibrosis Therapeutics Market– Route of Administration Analysis
  • 5.1. Global Cystic Fibrosis Therapeutics Market overview: By Route of Administration
    • 5.1.1. Global Cystic Fibrosis Therapeutics Market share, By Route of Administration , 2024 and 2032
  • 5.2. Inhaled
    • 5.2.1. Global Cystic Fibrosis Therapeutics Market By Inhaled, 2024–2032 (USD Billion)
  • 5.3. Oral
    • 5.3.1. Global Cystic Fibrosis Therapeutics Market By Oral, 2024–2032 (USD Billion)
• Chapter 6. Global Cystic Fibrosis Therapeutics Market– Drug Class Analysis
  • 6.1. Global Cystic Fibrosis Therapeutics Market overview: By Drug Class
    • 6.1.1. Global Cystic Fibrosis Therapeutics Market share, By Drug Class , 2024 and 2032
  • 6.2. Muculytic
    • 6.2.1. Global Cystic Fibrosis Therapeutics Market By Muculytic, 2024–2032 (USD Billion)
  • 6.3. Pancreatic Enzyme Supplements
    • 6.3.1. Global Cystic Fibrosis Therapeutics Market By Pancreatic Enzyme Supplements, 2024–2032 (USD Billion)
  • 6.4. CFTR Modulators
    • 6.4.1. Global Cystic Fibrosis Therapeutics Market By CFTR Modulators, 2024–2032 (USD Billion)
  • 6.5. Bronchodilators
    • 6.5.1. Global Cystic Fibrosis Therapeutics Market By Bronchodilators, 2024–2032 (USD Billion)
• Chapter 7. Company Profiles
  • 7.1. Novartis AG
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Genentech, Inc.
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Vertex Pharmaceuticals Incorporated
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Gilead Sciences, Inc.
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. GlaxoSmithKline Plc
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. AbbVie Inc.
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development
  • 7.7. Allergan plc
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Portfolio
    • 7.7.4. Business Strategy
    • 7.7.5. Recent Development
  • 7.8. Johnson & Johnson
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Portfolio
    • 7.8.4. Business Strategy
    • 7.8.5. Recent Development
  • 7.9. Mylan N.V.
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Product Portfolio
    • 7.9.4. Business Strategy
    • 7.9.5. Recent Development
  • 7.10. Pharmaxis Ltd
    • 7.10.1. Overview
    • 7.10.2. Financials
    • 7.10.3. Product Portfolio
    • 7.10.4. Business Strategy
    • 7.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Cystic Fibrosis Therapeutics Market, 2024–2032 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Cystic Fibrosis Therapeutics Market attractiveness, By Route of Administration  
6. Global Cystic Fibrosis Therapeutics Market attractiveness, By Drug Class 
7. Global Cystic Fibrosis Therapeutics Market Share by Route of Administration  ,2024 and 2032 (USD Billion)
8. Global Cystic Fibrosis Therapeutics Market by Inhaled,2024–2032 (USD Billion)
9. Global Cystic Fibrosis Therapeutics Market by Oral ,2024–2032 (USD Billion)
10. Global Cystic Fibrosis Therapeutics Market Share By Drug Class ,2024 and 2032 (USD Billion)
11. Global Cystic Fibrosis Therapeutics Market by Mucolytic,2024–2032 (USD Billion)
12. Global Cystic Fibrosis Therapeutics Market, By Pancreatic Enzyme Supplements, 2024–2032 (USD Billion)
13. Global Cystic Fibrosis Therapeutics Market, By CFTR Modulators, 2024–2032 (USD Billion)
14. Global Cystic Fibrosis Therapeutics Market, By Bronchodilators, 2024–2032 (USD Billion)
15. Global Cystic Fibrosis Therapeutics Market share, by Region, 2024 and 2032
16. North America Cystic Fibrosis Therapeutics Market, 2024–2032 (USD Billion)
17. Europe Cystic Fibrosis Therapeutics Market, 2024–2032 (USD Billion)
18. Asia Pacific Cystic Fibrosis Therapeutics Market, 2024–2032 (USD Billion)
19. Latin America Cystic Fibrosis Therapeutics Market, 2024–2032 (USD Billion)
20. The Middle East and Africa Cystic Fibrosis Therapeutics Market, 2024–2032 (USD Billion)

Table Of Tables

List of Tables

1. Global Cystic Fibrosis Therapeutics Market: snapshot
2. Drivers of the Cystic Fibrosis Therapeutics Market: impact analysis
3. North America Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
4. North America Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
5. The U.S. Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
6. The U.S. Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
7. Rest of North America Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
8. Rest of North America Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
9. Europe Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
10. Europe Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
11. UK Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
12. UK Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
13. France Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
14. France Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
15. Germany Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
16. Germany Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
17. Rest of Europe Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
18. Rest of Europe Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
19. Asia Pacific Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
20. Asia Pacific Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
21. China Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
22. China Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
23. Japan Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
24. Japan Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
25. India Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
26. India Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
27. Rest of Asia Pacific Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
28. Rest of Asia Pacific Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
29. Latin America Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
30. Latin America Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
31. Brazil Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
32. Brazil Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
33. Rest of Latin America Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
34. Rest of Latin America Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
35. The Middle East and Africa Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
36. The Middle East and Africa Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
37. Saudi Arabia Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
38. Saudi Arabia Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
39. South Africa Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
40. South Africa Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)
41. Rest of the Middle East & Africa Cystic Fibrosis Therapeutics Market revenue, By Route of Administration  , 2024–2032 (USD Billion)
42. Rest of the Middle East & Africa Cystic Fibrosis Therapeutics Market revenue, By Drug Class , 2024–2032 (USD Billion)